Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
Open Access
- 5 November 2020
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 9 (11) , 778
Abstract
The multidrug-resistant yeast Candida auris is associated with invasive infections in critically ill patients and has been isolated in different countries worldwide. Ease of spread, prolonged persistence in the environment and antifungal drug resistance pose a significant concern for the prevention of transmission and management of patients with C. auris infections. Early and correct identification of patients colonized with C. auris is critical in containing its spread. However, this may be complicated by C. auris strains being misidentified as other phylogenetically related pathogens. In this review, we offer a brief overview highlighting some of the critical aspects of sample collection, laboratory culture-dependent and independent identification and the susceptibility profile of C. auris.Keywords
This publication has 82 references indexed in Scilit:
- Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida aurisBMC Genomics, 2015
- Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest MethodJournal of Clinical Microbiology, 2015
- Candida auris–Associated Candidemia, South AfricaEmerging Infectious Diseases, 2014
- New Clonal Strain ofCandida auris, Delhi, IndiaEmerging Infectious Diseases, 2013
- Rapid Antifungal Susceptibility Testing by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry AnalysisJournal of Clinical Microbiology, 2013
- Candidemia caused by amphotericin B and Fluconazole resistant Candida aurisIndian Journal of Medical Microbiology, 2013
- Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic YeastsJournal of Clinical Microbiology, 2012
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida aurisJournal of Clinical Microbiology, 2011
- Regulatory Circuitry Governing Fungal Development, Drug Resistance, and DiseaseMicrobiology and Molecular Biology Reviews, 2011
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalMicrobiology and Immunology, 2009